PulseTech delivers Startup Bangladesh’s first multi-fold return after revenue surge
In young startup ecosystems, the first meaningful return matters almost as much as the cheque that produced it. It gives founders, investors and policymakers something more concrete than optimism: proof that local companies can grow fast, make money, and return capital. Bangladesh has now reached one of those moments. Startup Bangladesh, the government-backed venture capital […] The post…
PulseTech, a Dhaka-based pharmaceutical distribution startup, has achieved a multi-fold return on investment for Startup Bangladesh, the government-backed venture capital fund. The company has grown from $2 million to $150 million in annualized revenue in just two years. Startup Bangladesh invested in PulseTech in 2024, though the exact size of the original investment or return multiple has not been disclosed.
The milestone validates the fund's catalytic investment approach and commitment to backing globally competitive Bangladeshi startups. PulseTech operates in a fragmented pharmaceutical market worth about $6 billion in Bangladesh, where independent pharmacies often buy from multiple suppliers, leading to inefficiencies in pricing, availability, and delivery.
The company's app-based ordering and delivery network, MedBox, enables small pharmacies to source authentic medicines through a licensed distributor and receive same-day delivery. PulseTech has also introduced financing, pharmacy software, and a franchise network to deepen its relationship with pharmacies. The company maintains profitability while growing revenue by an average of 20% month-on-month and now serves over 14,000 retail pharmacies in Dhaka, reaching more than 8.5 million people with authentic, counterfeit-free medicines.
Written by urgent.news from e27's reporting — not their text. Machine-written; read the original for the full account.
